Literature DB >> 28526803

Acute exacerbations of idiopathic pulmonary fibrosis: tough to define; tougher to manage.

Nathan Hambly1, Gerard Cox1, Martin Kolb2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28526803     DOI： 10.1183/13993003.00811-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

1.  Epithelial Expression of an Interstitial Lung Disease-Associated Mutation in Surfactant Protein-C Modulates Recruitment and Activation of Key Myeloid Cell Populations in Mice.

Authors:  Alessandro Venosa; Jeremy Katzen; Yaniv Tomer; Meghan Kopp; Sarita Jamil; Scott J Russo; Surafel Mulugeta; Michael F Beers
Journal:  J Immunol       Date:  2019-03-25       Impact factor: 5.422

2.  Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Yaniv Dotan; William B Shapiro; Eneida Male; Eduardo C Dominguez; Amandeep Aneja; Zhao Huaqing; Chandra Dass; Kartik Shenoy; Nathaniel Marchetti; Francis C Cordova; Gerard J Criner; A James Mamary
Journal:  ERJ Open Res       Date:  2020-10-05

3.  Immunophenotyping of Acute Inflammatory Exacerbations of Lung Injury Driven by Mutant Surfactant Protein-C: A Role for Inflammatory Eosinophils.

Authors:  Jacklyn Nguyen; Brittnie S Armstrong; Sophie Cowman; Yaniv Tomer; Shivakumar R Veerabhadraiah; Michael F Beers; Alessandro Venosa
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

4.  Role of CCR2+ Myeloid Cells in Inflammation Responses Driven by Expression of a Surfactant Protein-C Mutant in the Alveolar Epithelium.

Authors:  Alessandro Venosa; Sophie Cowman; Jeremy Katzen; Yaniv Tomer; Brittnie S Armstrong; Surafel Mulugeta; Michael F Beers
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.